Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
You must be a Standard 1 Year member to access this content.
Sidley Austin advised IDEX Corporation on the offering, and Davis Polk & Wardwell advised the joint book-running managers and representatives of the several underwriters. IDEX Corporation...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised ProKidney, while Paul Hastings advised Jefferies, J.P. Morgan, and Guggenheim Securities, as joint book-running managers, in the transaction. ProKidney Corp. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised Tyson Foods, Inc. on the offering, Weil, Gotshal & Manges advised the underwriters. Tyson Foods, Inc. (NYSE: TSN) announced its offerings, consisting of...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom advised Perella Weinberg Partners on the offering, and Davis Polk & Wardwell advised the underwriter. Perella Weinberg Partners (Nasdaq: PWP)...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Bristol Myers Squibb on the offering, and Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters. Bristol...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Prime Medicine and Wilson Sonsini Goodrich & Rosati advised Prime Medicine on IP matters related to the transaction, while Davis Polk & Wardwell...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised the several initial purchasers on the offering. Immunocore Holdings plc (Immunocore) (Nasdaq: IMCR) announced the pricing of $350.0 million aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Bristol Myers Squibb Company on the offering, while Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters....
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised Marsh McLennan, and Willkie Farr & Gallagher advised the joint book-running managers on the offering. Marsh McLennan (NYSE: MMC) announced it...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Editas Medicine, Inc. (Nasdaq: EDIT) announced the pricing of an underwritten offering of 12,500,000 shares of its...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Privia Health Group, Goodwin Procter advised the underwriter, Maples and Calder advised MBD 2013 Holdings and Bridge Street 2013 Holdings, while Mourant Ozannes...
You must be a Standard 1 Year member to access this content.
